Company intelligence / Profile preview

Shandong New Era Pharmaceutical

Weihai City, Shandong, Chinaen.newerachem.cn ↗

Ownership: Private
Employees: ~250
Development stage: Other

Overview

Shandong New Era Pharmaceutical is an active Chinese manufacturer specializing in pharmaceutical intermediates, fluorosilicon fine chemicals, new materials, green polymer materials, and high-end chemical equipment. The company operates at commercial scale with global export capabilities. No clinical trial results are reported as it does not develop finished drugs but supplies key ingredients for further drug development or manufacturing.

Modalities: Small molecule
Industry: Chemicals & Materials

Beyond the preview

Go deeper on Shandong New Era Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shandong New Era Pharmaceutical.

Explore the full profile